Previous Article | Next Article 
Applied and Environmental Microbiology, December 1998, p. 5012-5015, Vol. 64, No. 12
0099-2240/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Isolation, Purification, and Characterization of
the PR Oxidase from Penicillium roqueforti
Shenq-Chyi
Chang,*
Wen-Yee
Lei,
Ying-Chieh
Tsai, and
Yau-Huei
Wei
Department of Biochemistry, National
Yang-Ming University, Taipei, Taiwan, Republic of China
Received 4 May 1998/Accepted 15 September 1998
 |
ABSTRACT |
The PR oxidase, an extracellular enzyme, involved in the conversion
of PR toxin into PR acid, was purified from the culture broth of
Penicillium roqueforti ATCC 48936. The enzyme has a pI of
4.5 and a molecular mass of approximately 88 kDa, and it is a monomer.
The optimum pH for this enzyme is ca. 4.0, and the optimum temperature
is 50°C.
 |
TEXT |
Penicillium roqueforti is
a fungal species traditionally used in the ripening of French Roquefort
cheese. Since the discovery of PR toxin by Wei et al. (20),
several other secondary metabolites related to PR toxin by P. roqueforti, such as eremofortins A, B, C, D, and E, have been
isolated and characterized (2, 9-11). Recently, we found
that another secondary metabolite (PR acid) is produced by P. roqueforti (6). Among these metabolites, only the PR
toxin is lethal to rats, mice, and cats (7, 17). PR toxin
inhibits RNA and protein synthesis (13, 14); the activities
of the DNA polymerases
,
, and
(8, 18); and mitochondrial respiration and oxidative phosphorylation in animal cells (18, 22). It also alters the genetic activities of
Saccharomyces cerevisiae and Neurospora
crassa (19). The disappearance of PR toxin has
been associated with an increase in PR acid (6). Moreover,
the structures of the PR toxin
(C17H20O6) and PR acid (C17H20O7) are closely related.
Both compounds differ by only an aldehyde (PR toxin) and a carboxyl
group (PR acid) at the C-12 position (6, 16). In previous
studies, we established that eremofortin C is the precursor of PR toxin
(3) and that eremofortin C is transformed into PR toxin by
eremofortin C oxidase (21). Using these studies as models,
we discovered that an enzyme in the culture medium of the fungus was
responsible for the transformation of PR toxin into PR acid. Therefore,
this study was designed to isolate, purify, and characterize this
enzyme. Our results may elucidate the metabolic pathway of PR toxin in
the culture medium of P. roqueforti.
P. roqueforti ATCC 48936 was maintained on potato dextrose
agar slants at 4°C. To obtain high yields of PR toxin and other secondary metabolites, we grew the fungus in YESC medium, which contains 1% yeast extract, 7.5% sucrose, and 20% corn extract (4). Liquid medium (150 ml) was incubated in a Roux bottle (600 ml) to a final concentration of 5 × 104
spores/ml and then incubated at 24°C as a stationary culture. PR
toxin and PR acid were isolated from the culture medium and further
purified by a previously described method (6, 20).
The amounts of PR toxin and PR acid were quantitatively analyzed
by high-performance liquid chromatography (HPLC). A model 510 liquid chromatograph equipped with a model 486 tunable absorbance detector set at 254 nm was used with a model 740 data module (all from
Waters). Separation was achieved with a Cosmosil 10 SL column (25 cm by
4.6 mm) for PR toxin and a Cosmosil 10 C18 column (25 cm by
4.6 mm) for PR acid. PR toxin was measured with chloroform as the
solvent at a flow rate of 2 ml/min, as described by Moreau et al.
(12). PR acid was assayed with methanol-H2O
(2:3) containing 20 mM citrate-phosphate buffer (pH 3.0) as the mobile
phase at a flow rate of 1.5 ml/min (6). The retention times
of PR toxin (2 min) and PR acid (8.8 min) were verified with their
respective standards. The amounts of these two compounds in the sample
were determined by measuring the peak area of each compound in the chromatogram against the peak of a known standard.
The activity of PR oxidase was determined by HPLC analysis of the
amount of PR toxin that converted to PR acid with a suitable amount of
the enzyme. The assay mixture, in a total volume of 10 ml, contained
6.2 µmol of PR toxin (dissolved in 45 µl of methanol), 0.5 ml of
the enzyme solution, and 20 mM citrate-phosphate buffer (pH 5.0). The
reaction proceeded at 30°C for 10 min and then terminated after the
addition of 5 ml of chloroform-acetic acid (6:1). After thorough
mixing, the organic layer was collected. An aliquot of 20 µl was
injected into an HPLC column for the measurement of the amount of PR
acid that was converted from PR toxin by the enzyme. One unit of the
enzyme activity was defined as the amount of enzyme that catalyzed the
transformation of 1 µmol of PR toxin to PR acid per min under the
assay conditions.
The culture medium of P. roqueforti was collected on day 22, when the PR oxidase activity reached maximum. Spores were removed by
centrifugation at 9,000 × g for 20 min. The
supernatant (7 liters) was concentrated by use of a polyfiber
ultrafiltration system with a type SIY 10 membrane cartridge having a
10,000-molecular-weight cutoff (Amicon, Inc.). The concentrate was then
slowly mixed with ammonium sulfate to 80% by constant stirring at
4°C, and the final precipitate was dissolved in 20 mM
citrate-phosphate buffer (pH 5.0). The resultant enzyme solution was
dialyzed against the same buffer. The dialysate was put onto a
Q-Sepharose column (5.5 by 20 cm) preequilibrated with 20 mM
citrate-phosphate buffer (pH 5.0). After being washed with 2 bed
volumes of the column buffer, the column was eluted with a stepwise
gradient of 50, 100, 250, and 500 mM NaCl in the same buffer (300 ml
each). The fractions containing the enzyme activity were pooled and
concentrated with a membrane filter apparatus with an XM 50 membrane
(Amicon, Inc.). The enzyme solution was chromatographed on a
Phenyl-TOYOPEARL 650 M column (1.6 by 30 cm) equilibrated with 20 mM
citrate-phosphate buffer (pH 5.0) containing 2 M
(NH4)2SO4. The enzyme was eluted by
lowering the ionic strength of the
(NH4)2SO4. The active fractions that eluted with 0 M (NH2)2SO4 were
combined and concentrated as in the previous step. The concentrate was
further purified by analytical gel filtration on an HPLC by using a
Bio-Sil SEC-250 column (0.78 by 30 cm; Bio-Rad, Richmond, Calif.).
Elution was performed with 20 mM citrate-phosphate buffer (pH 5.0)
containing 0.25 M NaCl.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
with 7.5% polyacrylamide gel and isoelectric focusing were performed
as described previously (21). For examination of the
glycoprotein nature of PR oxidase, the purified enzyme was subjected to
periodic acid schiff staining according to the method of Thotakura and
Bahl (15). To estimate the sugar content of PR oxidase, the
purified enzyme was deglycosylated as described previously
(21). The enzyme was incubated in a solution containing 0.2 U of endoglycosidase (Endo F; Sigma Chemical Co., St. Louis, Mo.),
0.1% SDS, 1% Triton X-100, 50 mM EDTA, 1% 2-mercaptoethanol, and 50 mM sodium phosphate (pH 5.0). The reaction was conducted at 37°C for
5 h. These conditions were chosen to demonstrate complete deglycosylation. The decrease in molecular mass compared to that of the
native enzyme was considered the mass of the sugar residue of PR
oxidase. Protein concentrations were determined as described by
Bradford (1) with a Bio-Rad protein assay kit.
In our previous study (6), we observed that PR toxin
appeared earlier than PR acid and that with time the amount of PR toxin decreased while that of PR toxin concomitantly increased. When PR
toxin was incubated in the buffer solution containing the culture
medium that had been grown with P. roqueforti, PR acid
appeared and the amount of PR toxin decreased. These results suggest
that the culture medium contains the enzyme system that is responsible
for the transformation of PR toxin into PR acid. A similar finding was
made with the crude extract of the mycelium of the fungus. When we
examined the activity of the enzyme during the growth period of the
fungus, we found that maximum activity occurred on day 22 of the culture.
When the enzyme activity reached maximum, the culture
medium was harvested. The purification of PR oxidase is shown
in Table 1. The crude enzyme, after
concentration by ultrafiltration, was subjected to a series of
purification procedures, including ammonium sulfate fractionation,
ion-exchange chromatography on a Q-Sepharose column, hydrophobic
chromatography on a Phenyl-TOYOPEARL 650 M column, and gel
chromatography on an HPLC Bio-Sil SEC-250 column. The PR oxidase was
purified 6.5-fold, giving a 10.2% yield. The specific activity of
the final preparation was 201 U/mg. The purified PR oxidase showed a
single band by SDS-PAGE (Fig. 1).

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 1.
SDS-PAGE of the purified PR oxidase. Lane 1, molecular
mass markers; lane 2, purified PR oxidase. The proteins were stained
with Coomassie brilliant blue.
|
|
There were three major protein peaks when the enzyme was purified on an
HPLC Bio-Sil SEC-250 column, but only one showed oxidative activity.
The native molecular mass of this peak was ca. 90,000 Da. SDS-PAGE
revealed that the molecular mass of the PR oxidase was approximately
88,000 Da, which indicates that the native enzyme is a monomer.
The enzyme was shown to be a glycoprotein by periodic acid schiff
staining. By use of a commercial endoglycosidase, we were able to
remove the sugar residues from PR oxidase. The truncated enzyme
molecule had a molecular mass of 67,000 Da, which indicated that the
mass of the sugar residues was about 21,000 Da and accounted for 23.9%
of the molecular mass of the native enzyme molecule. When analyzed by
isoelectrofocusing in the ampholine polyacrylamide gel, PR oxidase
exhibited a single band. The pI of PR oxidase was estimated to be 4.5, which indicates that the enzyme is an acidic protein.
As shown in Fig. 2A, the enzyme showed
maximum activity at pH 4.0. The activity of the enzyme was estimated at
various temperatures between 30 and 80°C. The results showed that the
optimum temperature for the oxidation of PR toxin was 50°C (Fig. 2B).
The enzyme was incubated at various temperatures for 20 min, and the
remaining enzyme activity was measured under standard conditions. The
enzyme was stable below 60°C. Thirty-eight and 23% of initial
activity remained after incubation at 70 and 80°C, respectively. The
enzyme activity was observed in the pH range of 3.0 to 9.0 upon
incubation at 30°C for 30 min. The enzyme activity was stable between
pHs 4 and 6. Approximately 50% of the activity was retained at pHs 3.0 and 7.0. Only a very small fraction of the activity remained at pH 9.0.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 2.
Effects of pH (A) and temperature (B) on the activity of
PR oxidase from P. roqueforti. (A) Enzyme activity was
assayed under the standard assay conditions except that the following
buffers (20 mM) were used: citrate-phosphate ( - ), sodium
phosphate ( - ), and Tris-HCl ( - ). (B) Assays were performed
at various temperatures under the standard enzyme assay conditions.
Relative activity is expressed as a percentage of the maximum
activity.
|
|
Since the enzyme catalyzed the oxidation of the -CHO group of PR
toxin to the -COOH group of PR acid (Fig.
3), the enzyme must be either an aldehyde
dehydrogenase or an oxidase. In this study, we found that the enzyme
does not require NAD+ or NADP+ as a cofactor to
catalyze the transformation. By using the coupling assay in the
presence of peroxidase and 4-aminoantipyrine plus phenol, we were able
to determine the oxidase activity of the enzyme. The oxidase activity
was found to be dose dependent and correlated very well with the
transforming activity of the enzyme. Thus, the transforming enzyme is
probably an oxidase.
PR toxin was the first and only toxic secondary metabolite of P. roqueforti (7, 17). In the past few years, we have come across several secondary metabolites related to PR toxin and observed that they are produced sequentially in the culture medium of the fungus (5, 6). The compounds were isolated, purified, and identified as PR-imine (C17H21O5N),
PR acid (C17H20O7), and
PR-amide (C17H21O6N), respectively.
Moreover, we found that eremofortin C is transformed to PR toxin by EC
oxidase (21). As part of our effort to understand the
degradative pathway of the toxin, we discovered and purified the
oxidizing enzyme that catalyzes the conversion of PR toxin to PR acid.
In addition, eremofortin C was added to the assay system to see whether
PR oxidase could oxidize eremofortin C to PR acid. The negative results
indicated that PR oxidase is specific for PR toxin.
 |
ACKNOWLEDGMENTS |
This work was supported by grant NSC 84-2331-B010-059 from the
National Science Council of the Republic of China. Shenq-Chyi Chang
expresses his appreciation for a research award from the Medical
Research and Advancement Foundation in memory of Chi-Shuen Tsou during
the course of this study.
We are also grateful to Shung-Chang Jong for technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biochemistry, National Yang-Ming University, Taipei 112, Taiwan,
Republic of China. Phone: 886-2-28267120. Fax: 886-2-28264843. E-mail: scchang{at}mailsrv.ym.edu.tw.
 |
REFERENCES |
| 1.
|
Bradford, M. M.
1976.
A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of dye-binding.
Anal. Biochem.
72:248-254[Medline].
|
| 2.
|
Cacan, M.,
S. Moreau, and R. Tailliez.
1977.
In vitro metabolism of Penicillium roqueforti toxin (PRT) and a structurally related compound, eremofortin A, by rat liver.
Toxicology
8:205-212[Medline].
|
| 3.
|
Chang, S. C.,
Y. H. Wei,
M. L. Liu, and R. D. Wei.
1985.
Isolation and some properties of the enzyme that transforms eremofortin C to PR toxin.
Appl. Environ. Microbiol.
49:1455-1460[Abstract/Free Full Text].
|
| 4.
|
Chang, S. C.,
Y. H. Wei,
D. L. Wei,
Y. Y. Chen, and S. C. Jong.
1991.
Factors affecting the production of eremofortin C and PR toxin in Penicillium roqueforti.
Appl. Environ. Microbiol.
57:2581-2585[Abstract/Free Full Text].
|
| 5.
|
Chang, S. C.,
K. L. Lu, and S. F. Yeh.
1993.
Secondary metabolites resulting from degradation of PR toxin by Penicillium roqueforti.
Appl. Environ. Microbiol.
59:981-986[Abstract/Free Full Text].
|
| 6.
|
Chang, S. C.,
S. F. Yeh,
S. Y. Li,
W. Y. Lei, and M. Y. Chen.
1996.
A novel secondary metabolite relative to the degradation of PR toxin by Penicillium roqueforti.
Curr. Microbiol.
32:141-146[Medline].
|
| 7.
|
Chen, F. C.,
C. F. Chen, and R. D. Wei.
1982.
Acute toxicity of PR toxin, a mycotoxin from Penicillium roqueforti.
Toxicon
20:433-441[Medline].
|
| 8.
|
Lee, W. Y. H.,
S. C. Fang, and R. D. Wei.
1984.
The effects of Penicillium roqueforti toxin on the activity of rat hepatic DNA polymerases.
Toxicology
33:43-57[Medline].
|
| 9.
|
Moreau, S.,
J. Biguet,
A. Lablache-Combier,
F. Baert,
M. Foulon, and C. Delfosse.
1980.
Structures et stéréochimie des sesquitèrpenes de Penicillium roqueforti PR toxin et érémofortines A, B, C, D, E.
Tetrahedron
36:2989-2997.
|
| 10.
|
Moreau, S.,
M. Cacan, and A. Lablache-Combier.
1977.
Eremofortin C, a new metabolite obtained from Penicillium roqueforti and from biotransformation of PR toxin.
J. Org. Chem.
42:2632-2634[Medline].
|
| 11.
|
Moreau, S.,
A. Lablache-Combier, and J. Biguet.
1980.
Production of eremofortins A, B, and C relative to formation of PR toxin by Penicillium roqueforti.
Appl. Environ. Microbiol.
39:770-776[Abstract/Free Full Text].
|
| 12.
|
Moreau, S.,
A. Masset, and J. Biguet.
1979.
Resolution of Penicillium roqueforti toxin and eremofortins A, B, and C by high-performance liquid chromatography.
Appl. Environ. Microbiol.
37:1059-1062[Abstract/Free Full Text].
|
| 13.
|
Moule, Y.,
M. Jemmali, and N. Darracq.
1978.
Inhibition of protein synthesis by PR toxin, a mycotoxin from Penicillium roqueforti.
FEBS Lett.
88:341-344[Medline].
|
| 14.
|
Moule, Y.,
M. Jemmali, and N. Rousseau.
1976.
Mechanism of the inhibition of transcription by PR toxin, a mycotoxin from Penicillium roqueforti.
Chem.-Biol. Interact.
14:207-216[Medline].
|
| 15.
|
Thotakura, N. R., and O. P. Bahl.
1987.
Enzymatic deglycosylation of glycoproteins.
Methods Enzymol.
138:350-358[Medline].
|
| 16.
|
Wei, R. D.,
H. K. Schnoes,
P. A. Hart, and F. M. Strong.
1975.
The structure of PR toxin, a mycotoxin from Penicillium roqueforti.
Tetrahedron
31:109-114.
|
| 17.
|
Wei, R. D.,
H. K. Schnoes,
E. B. Smalley,
S. S. Lee,
Y. N. Chang, and F. M. Strong.
1976.
Production, isolation, chemistry, and biological properties of Penicillium roqueforti toxin., p. 137-144.
In
A. Ohaska, K. Hayashi, and Y. Sawai (ed.), Animal, plant, and microbial toxins, vol. 2. Plenum Press, New York, N.Y.
|
| 18.
|
Wei, R. D.,
W. Y. H. Lee, and Y. H. Wei.
1985.
Some biochemical responses to PR toxin, a mycotoxin from Penicillium roqueforti, p. 337-348.
In
J. Lacey (ed.), Trichothecense and other mycotoxins. John Wiley & Sons, Inc., New York, N.Y.
|
| 19.
|
Wei, R. D.,
T. M. Ong,
W. Z. Whong,
D. Frezza,
G. Bronzetti, and E. Zeizer.
1979.
Genetic effects of PR toxin in eukaryotic microorganisms.
Environ. Mutagen.
1:45-53[Medline].
|
| 20.
|
Wei, R. D.,
P. E. Still,
E. B. Smalley,
H. K. Schnoes, and F. M. Strong.
1973.
Isolation and partial characterization of a mycotoxin from Penicillium roqueforti.
Appl. Microbiol.
25:111-114[Medline].
|
| 21.
|
Wei, Y. H.,
S. C. Chang,
S. Y. Li, and C. Y. Lu.
1989.
Secondary metabolites and enzymes involved in the biosynthesis and degradation of PR toxin.
Acad. Sin. Inst. Bot. Monogr. Ser.
9:371-390.
|
| 22.
|
Wei, Y. H.,
W. H. Ding, and R. D. Wei.
1984.
Biochemical effects of PR toxin on rat liver mitochondrial respiration and oxidation phosphorylation.
Arch. Biochem. Biophys.
230:400-411[Medline].
|
Applied and Environmental Microbiology, December 1998, p. 5012-5015, Vol. 64, No. 12
0099-2240/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.